{"nct_id":"NCT00823862","title":"Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection","status":"COMPLETED","status_verified_date":"2019-04","start_date":"2008-10","start_date_type":null,"primary_completion_date":"2009-12","primary_completion_date_type":"ACTUAL","completion_date":"2010-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["DVAX"]}